Study of Doxorubicin and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) and Intraoperative Brachytherapy for Unresectable or Refractory Pelvic and Abdominal Rhabdomyosarcoma and Undifferentiated Sarcomas in Children

NCT03111069 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped PI withdrew study

Conditions

Malignant Neoplasms of Mesothelial and Soft Tissue
Rhabdomyosarcoma, Pelvic
Rhabdomyosarcoma, Abdominal

Interventions

PROCEDURE: Abdominal Surgery
DRUG: Doxorubicin
RADIATION: Intra-Operative Radiation

Sponsor

M.D. Anderson Cancer Center